Literature DB >> 2987714

Serum angiotensin-converting enzyme increases during hemodialysis. Evidence for injury of the pulmonary vascular endothelium?

A H Nielsen, F Knudsen, S D Kristensen.   

Abstract

In 19 patients hemodialysis was associated with significant decreases in arterial oxygen tension and leukocyte count. After 240 min of dialysis serum angiotensin-converting enzyme (ACE) corrected for hemoconcentration increased 14.3% (p less than 0.001) indicating injury of the vascular endothelium during hemodialysis. It is suggested that the increase in serum ACE is due to a complement-mediated sequestration of leukocytes in the pulmonary vasculature leading to injury of the vascular endothelium with interstitial edema and pulmonary dysfunction. Furthermore, it is suggested that serum ACE analysis may prove a new method to assess biocompatibility of materials used in devices for extracorporeal circulation.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2987714     DOI: 10.1159/000183438

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  4 in total

1.  Angiotensin converting enzyme (ACE) in scleroderma.

Authors:  M Matucci Cerinic; M Borsotti; R Barbieri; A Lombardi
Journal:  Clin Rheumatol       Date:  1987-06       Impact factor: 2.980

2.  Response of serum angiotensin converting enzyme, plasma renin activity and plasma aldosterone to conventional dialysis in patients on chronic haemodialysis.

Authors:  C Letizia; S Mazzaferro; S Morabito; A De Ciocchis; S Cerci; C D'Ambrosio; G A Cinotti; D Scavo
Journal:  Int Urol Nephrol       Date:  1995       Impact factor: 2.370

3.  Changes of plasma angiotensin-converting enzyme activity during hemodialysis.

Authors:  W S Koo; Y J Lee; H S Kim; S Y Kim; E J Choi; Y S Chang; Y S Yoon; B K Bang
Journal:  Korean J Intern Med       Date:  1987-01       Impact factor: 2.884

Review 4.  Some Aspects of the Renin-Angiotensin-System in Hemodialysis Patients.

Authors:  Umar Malik; Veena Raizada
Journal:  Kidney Blood Press Res       Date:  2015-11-29       Impact factor: 2.687

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.